TABLE 1

Characteristics of the patient population before the start of the study

C-peptidePlacebo
n2620
Age (years)30 ± 1.428 ± 1.4
Proportion of women7/268/20
Body weight (kg)76 ± 1.775 ± 2.9
Body height (m)1.77 ± 0.021.76 ± 0.02
Diabetes duration (years)9 ± 0.710 ± 0.7
Daily insulin requirement (units/24 h)61 ± 4.661 ± 4.2
HbA1c (%)7.0 ± 0.246.7 ± 0.20
Systolic blood pressure (mmHg)121 ± 1.9123 ± 2.9
Diastolic blood pressure (mmHg)73 ± 1.375 ± 1.6
  • Data are means ± SE. None of the variables differed significantly between the two patient groups.